Holen Sie sich die Stockscreener-App
79.03
1.97%
1.53
Handel nachbörslich:
79.03
Finanzdaten der Kymera Therapeutics Inc-Aktie (KYMR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.84%
2.87
|
2.764 | 11.48 | 22.10 | 7.394 |
| Cost Of Revenue |
3.84%
2.87
|
2.764 | 11.48 | 22.10 | - |
| Gross Profit |
-
|
- | - | - | - |
Operating Expenses
|
5.75%
100.77
|
95.28 | 96.03 | 96.53 | 88.15 |
| Benefits Costs and Expenses |
89.85
|
- | - | 87.68 | 78.15 |
| Costs And Expenses |
5.70%
89.85
|
95.28 | 96.03 | 87.68 | 78.15 |
| Operating Income/Loss |
5.81%
-97.90
|
-92.52 | -84.56 | -74.43 | -80.75 |
| Income/Loss From Continuing Operations Before Tax |
3,247%
-86.98
|
2.764 | 11.48 | -65.58 | -70.75 |
| Income/Loss From Continuing Operations After Tax |
5.85%
-86.98
|
-82.17 | -76.61 | -65.58 | -70.75 |
|
Net Income/Loss
|
5.85%
-86.98
|
-82.17 | -76.61 | -65.58 | -70.75 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.90%
1.8374
|
87.30 | 80.45 | 80.15 | 1.7137 |
| Diluted Average Shares |
97.90%
1.8374
|
87.30 | 80.45 | 80.15 | 1.7137 |
| Basic Earnings Per Share |
4.26%
-0.98
|
-0.94 | -0.95 | -0.82 | -0.89 |
| Diluted Earnings Per Share |
4.26%
-0.98
|
-0.94 | -0.95 | -0.82 | -0.89 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):